JMP news Header

Meet us in California @ JPM Healthcare Week!

January 8–11, 2024, San Francisco, USA.

In the heart of San Francisco, where innovation converges with expertise, Arriello is ready to support your product journey at the 42nd Annual J.P. Morgan Healthcare Conference. As a premier gathering of health care visionaries, Arriello is eager to connect with global leaders, emerging companies, and investors who share a passion for advancing healthcare solutions.

About Arriello and Our Expertise:

Arriello guides innovative pharmaceutical, biotech and life sciences firms through every stage of product development, ensuring a smooth journey from discovery & development to market launch.

We take a holistic view of clinical safety and ongoing safety and quality. We strive to smooth the pathway to commercialisation or your next major milestone.

How we assist in the early lifecycle stages:

  • Understanding the pivotal role of a Target Product Profile (TPP), Arriello leverages it to de-risk the product development process. Our experts assist with stakeholder alignment, providing access to subject matter experts who have years of experience with this.
  • Assessing the feasibility of development plans is critical for the viability and overall value of a product. Arriello’s expertise spans regulatory strategy, safety, manufacturing, and quality considerations.
  • The crafting of a robust regulatory strategy is paramount in obtaining approvals and expediting the approval process, ultimately reducing time-to-market.
  • Compliance with CMC requirements is integral for regulatory approval and market acceptance. Arriello ensures consistent quality, building trust with stakeholders.
  • Early scientific advice plays a crucial role in aligning strategies with regulatory expectations, minimizing delays, and increasing the likelihood of successful submissions.
  • Our service bundle for Investigational New Drug (IND) and Clinical Trial Application (CTA) processes optimizes resources, accelerates timelines, and allows internal teams to focus on core competencies.
  • Commercialization readiness evaluation addresses market dynamics, payer landscapes, and supply chain considerations, facilitating a smooth transition from development to market launch.

Our team will be on-site over the week and have a meeting area booked for the duration in the heart of the event, ready to welcome you and discuss any questions you might have.

Meet Arriello’s Leadership:

  • Alan White, CEO
  • Anna Lukyanova, COO
  • Vic Cowper, CCO
  • Jayne Hunt, Principal Consultant – Regulatory Affairs
Alan Anna Vic Jayne

Connect with Arriello:

To understand more about how we might help or have a meeting with the team, contact the team directly:

via LinkedIn,


or through the event Bio Partnering site.

Latest News:

Celebrate Valeria Grigoriev, our regulatory specialist, a TOPRA Horizon Award finalist, showcasing excellence in regulatory affairs.
Rising Star in Regulatory Affairs: Valeria Grigoriev Finalist in the Prestigious TOPRA Horizon Award.
Arriello at Regulatory Affairs event TOPRA in Lisbon.
Arriello at Regulatory Affairs event TOPRA in Lisbon.
Industrial microbiology and quality risk management specialist Kate Coleman will join Arriello in September as VP of Quality & Compliance.
Arriello appoints experienced biotech expert, Kate Coleman as VP of Quality & Compliance.